Neurocrine Bioscience buy Jefferies Financial Group Inc.
Start price
19.08.24
/
50%
€133.70
Target price
19.08.25
€170.67
Performance (%)
-15.48%
End price
20.08.25
€113.00
Summary
This prediction ended on 20.08.25 with a price of €113.00. The prediction for Neurocrine Bioscience disappointed with a performance of -15.48%. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | 0.076% | 0.076% | 14.517% |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Jefferies Financial Group Inc. from $177.00 to $189.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten